PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, maternity, paediatric care, endoscopy, endoscopy, cath lab, stroke centre, and trauma centre. The company’s other services include acupuncture, anaesthesia, beauty and wellness, dermatology, dental and mouth, endocrine, digestive, vascular, neurology, ENT, haematology, nephrology, nutrient, consultancy, oncology, plastic and paediatric surgery, neurosurgery, obgyn and fertilization, ophthalmology, chemotherapy, psychiatrist, psychology, pulmonology, orthopaedic, and paediatric orthopaedic. The company was founded in 2013 and is based in Jakarta, Indonesia.
Metrics to compare | PRIM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRIMPeersSector | |
---|---|---|---|---|
P/E Ratio | −10.7x | 10.3x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price / Book | 0.2x | 1.2x | 2.6x | |
Price / LTM Sales | 0.6x | 1.8x | 2.9x | |
Upside (Analyst Target) | - | 22.5% | 51.4% | |
Fair Value Upside | Unlock | 4.3% | 9.5% | Unlock |